For the SUD Barometer, which was conducted for the first time at Startup Days, participants were asked about their business ...

The series of successes for Swiss healthcare start-ups continues. GlycoEra has secured about CHF 108 million: the funding will enable the start of clinical trials on humans. Trials for the first drug ...

Three startups—each offering pioneering solutions to tackle hospital-acquired infections, biomass deconstruction, and cybersecurity—have been selected to participate in leading European projects. The ...

The KlimUp support programme, run by Bluelion, supports start-ups and non-profit organizations with a focus on climate protection and the circular economy. Now in its fourth cycle, KlimUp will ...

Switzerland’s startup scene is booming, but many international investors are missing out. This exclusive lunchtime webinar connects global VCs and angel investors with top Swiss startups ready to ...

Hedera Dx, the European techbio company headquartered in Switzerland, just announced the closing of a €15 million Series A financing round to drive advanced cancer care. The funding will fuel Hedera ...

GlycoEra AG, a biotechnology company pioneering best-in-class extracellular protein degraders for the treatment of autoimmune diseases, closed an oversubscribed $130 million Series B financing. The ...

The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance for LEM Surgical’s Dynamis Robotic Surgical System, ...

AMINA Bank AG, a global crypto bank licensed in Switzerland, reports a record financial performance for 2024 including a 69% surge in revenue to USD $40.4 million and a remarkable 136% increase in ...

Yves Kilchenmann, CEO Nau media AG: «Für uns ist das ein erster Schritt in Richtung Print und zugleich die Tür zu zwei neuen Entwicklungsfeldern: dem Printprodukt selbst und der Distribution direkt in ...